News Focus
News Focus
Post# of 257644
Next 10
Followers 0
Posts 54
Boards Moderated 0
Alias Born 12/27/2003

Re: DewDiligence post# 1513

Thursday, 03/18/2004 2:14:58 PM

Thursday, March 18, 2004 2:14:58 PM

Post# of 257644
dew,

This company is not that far from you. They use a proprietary blood marker for a number of different ca's. Bladder ca test on market, prostate very soon or already approved.
Randy and I had shares in the company. Sounds good, but they have a very weird chart. I sold to buy GENR.

Regards to you.

lois

Matritech Inc
330 Nevada Street
Newton, MA 02460
Phone: (617) 928-0820
Fax: (617) 928-0821
Email: rsandberg@maritech.com
Web Site: http://www.matritech.corp


Index Membership:
N/A
Sector:
Healthcare
Industry:
Biotechnology & Drugs
Employees (last reported count):
50

REUTERS ABRIDGED BUSINESS SUMMARY
 

Matritech, Inc. developed and manufactures and markets cancer diagnostic products based on its proprietary nuclear matrix protein technology. In all its programs, the Company intends to use the basic technologies in development programs undertaken by Matritech or its licensees to create products or services that will generate medically useful information. It has identified three principal approaches to delivering this information, two of which are types of products. Lab Test Kits are generally sold for use in appropriately licensed clinical laboratories or doctor's office laboratories to perform lab-testing services. Point-of-Care Test Devices are generally sold for use in a medical facility or physician's office by medical personnel who need not be licensed to perform laboratory tests. Proprietary Laboratory Procedures are under development using the Company's technologies for prostate and breast cancer.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today